Ascorbic Acid in Combination with Chemotherapeutic Agents for Cancer


  • Michael J. Gonzalez University of Puerto Rico, Medical Sciences Campus, School of Public Health; San Juan PR; EDP University, Program of Naturopathic Sciences and Hato Rey, PR, Universidad Central del Caribe, School of Chiropractic
  • Jorge R. Miranda-Massari San Juan PR University of Puerto Rico, Medical Sciences Campus, School of Pharmacy and San Juan PR; EDP University, Program of Naturopathic Sciences
  • Jorge Duconge San Juan PR University of Puerto Rico, Medical Sciences Campus, School of Pharmacy;
  • Miguel J. Berdiel Bayamon, PR, Berdiel Clinic
  • Jose Olalde Ponce PR; Centro Medico Regenerativo (CMR), Bayamon, Caguas PR, USA



Ascorbic acid, Vitamin C, Chemotherapy


Cancer accounts for nearly one-quarter of deaths in the United States. The life expectancy after standard treatment for these patients is dismal. New treatment modalities should be considered and evaluated. Ascorbic Acid (AA, Vitamin C) is a relatively low cost and safe nutrient even when given at very high doses (intravenous) that could be a very relevant co-adjuvant in cancer treatment. In vitro and in vivo studies have shown benefit of using high dose intravenous vitamin C as adjuvant therapy in cancer patients. There is significant supporting evidence of the benefits of the use vitamin C with chemotherapy.


Prasad KN, Kumar A, Kochupillai Cole W. High dose of multiple antioxidants vitamins: Essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 1999; 18: 13-25. DOI:

Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controlled trials. Int J Cancer 2008; 123(6): 1227-1239. DOI:

Cancer survival rates for selected cancer sites by sex and race, Available at:

Gonzalez MJ, Miranda-Massari JR, Mora EM, Guzmán A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Román-Franco A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther 2005; 4(1): 32-44. DOI:

Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004; 3: 294-300. DOI:

Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide into tissue. Proc Natl Acad Sci USA 2005; 102: 13604-13609. DOI:

Chen Q, Espey MG, Sun AY, Lee JH, Krishna MC, Shacter E, Choyke PL, Pooput C, Kirk KL, Buettner GR, Levine M. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 2007; 104: 8749-8754. DOI:

Simone II C, Simone NL, Simone V. Simone CB. Anti-oxidants and other nutrients do not interfere with chemo-therapy or radiation therapy and can increase kill and increa-se survival, Part 1. Alternative Therapies 2007; 13(1): 22-28.

Simone II C, Simone NL, Simone V, Simone CB. Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Alternative Therapies 2007; 13(2): 40-47.

Hong SW, Jin DH, Hahm ES, Yim SH, Lim JS, Kim KI, Yang Y, Lee SS, Kang JS, L WJ, L WK, L MS. Ascorbate (vitamin C) induces cell death through the apoptosis-inducing factor in human breast cancer cells. Oncol Rept 2007; 18: 811-817. DOI:

Kao T, Meyers W, Post F. Inhibitory effect of ascorbic acid growth of leukemic and lymphoma cell lines. Cancer Lett 1993; 70: 101-106. DOI:

Isawaka I, Koyama N, Nogaki A, Maruyama S, Tamura A, Kim D, Hur D, Park H, Hwang YI, Lee WJ. Role of hydrogen peroxide in cytotoxic induction by ascorbates and other redox compounds. Anticancer Res 1998; 18: 4333-433.

Baader S, Bruchelt G, Carmine T, Lode H, Rieth A, Niethammer D. Ascorbic acid mediated iron release from cellular ferritin and its relation to the formation of DNA strand breaks in neuroblastomas cells. J Cancer Res Clin Oncol 1994; 120: 415-421. DOI:

Lee YS, Wurster RD. Potentiation of anti-proliferative effect of nitroprusside by ascorbate in human brain tumor cells. Cancer Lett 1994; 78: 19-23. DOI:

Maramag C, Menon M, Balaji KC, Reddy PG, Laxmanan S. Effect of vitamin C on prostate cancer cells in vitro: Effect on cell number, viability, and DNA synthesis. Prostate 1997; 32: 188-195.<188::AID-PROS5>3.0.CO;2-H DOI:<188::AID-PROS5>3.0.CO;2-H

Prasad KN. Modulation of the effect of tumor therapeutics agents by vitamin C. Life Sci 1980; 27: 275-280. DOI:

Park CH. Vitamin C in leukemia and preleukemia cell growth. Prog Clin Biol Res 1988; 259: 321-330.

Kurbacher CM, Wagner U, Kolster B, Andreotti PE, Krebs D, Bruckner HW. Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett 1996; 103, 183-189. DOI:

Prasad KN, Hernandez C, Edwards-Prasad J, Nelson J, Borus T, Robinson W A. Modification of the effect of tamoxifen, cis-platin, DTIC, and interferon-α2b on human melanoma cells in culture by a mixture of vitamins. Nutr Cancer 1994; 22: 233-245. DOI:

Prasad KN, Sinha PK, Ramanujam M, Sakamoto A. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture. Proc Natl Acad Sci USA 1979; 76: 829-832. DOI:

Chiang CD, Song EJ, Yang VC, Chao, CCK. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung cancer cells. Biochem J 1994; 301, 759-764. DOI:

Reddy VG, Khanna N, Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53. Biochem Biophys Res Commun 2001; 282: 409-415. DOI:

Patahk AK, Singh N, Khanna N, Reddy VG, Prasad KN, Kochupillai V. Potentiation of the effect of Paclitaxel and Carboplatin by antioxidant mixture on human lung cancer H520 cells. J Am Coll Nutr 2002; 18: 416-421. DOI:

Chen Q, Espey MG, Sun AY, Pooput C, Kirk KL, Krishna MC, Khosh DB, Drisko J, Levine M. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci USA 2008; Aug 12; 105(32): 11105-11109. DOI:

Casciari JJ, Riordan HD, Miranda-Massari JR, Gonzalez MJ. Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs. P R Health Sci J 2005; 24(2): 145-50.

Prasad KN. Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy. J Nutr 2004; 134: 3182S-3183S. DOI:

Cameron E, Pauling L, Leibovitz B. Ascorbic acid and cancer: A review. Cancer Res 1979; 39: 663-681.

Yeom CH, Jung GC, Song KJ. Changes of terminal cancer patients' health-related Quality of Life after high dose vitamin C administration. J Korean Med Sci 2007; 22: 7-11. DOI:

Riordan HD, Jackson JA, Schultz M. Case study: High-dose Iintravenous vitamin C in the treatment of a patient with adenocarcinoma of the kidney. J Orthomolec Med 1990; 5(1): 5-7.

Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, González MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A. Intravenous ascorbic acid: protocol for its application and use. Puerto Rico Health Sciences J 2003; 22(3): 287-290.

Drisko JA, Chapman J, Hunter VJ. The use of antioxidants with first-line chemotherapy in two cases of ovarian cancer. J Am Coll Nutr 2003; 22(2): 118-23. DOI:

Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesly RA, Levine M. Vitamin C pharmacokinetics: Implications for oral and intravenous use. Ann Intern Med 2004; 140(7): 533-538. DOI:




How to Cite

Gonzalez, M. J., Miranda-Massari, J. R. ., Duconge, J., Berdiel, M. J., & Olalde, J. (2022). Ascorbic Acid in Combination with Chemotherapeutic Agents for Cancer. Journal of Cancer Research Updates, 11, 17–21.